These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 535329)
21. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin). Pines A; Raafat H; Siddiqui GM J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340 [No Abstract] [Full Text] [Related]
22. [The relation between bacilli negative conversion rate and the number of combined sensitive antituberculous drugs in intermittent administration of rifampicin for severe pulmonary tuberculosis]. Tamura M; Yamazaki A; Tamura T; Takano S; Yamazaki M Kekkaku; 1973 Jul; 48(7):297-302. PubMed ID: 4200058 [No Abstract] [Full Text] [Related]
23. [Results of treatment with rifampicin in 39 patients hospitalized in our service during 1970-1971-1972]. Maalej M; Chabbou A; Zbiba M; El Gharbi B; Halfon S; El Gharbi T; Cheniti M; El Mekki L; Djen Ayah F; Chebbi ML; Jeguirim M; Ben Salah M Tunis Med; 1974; 52(6):313-6. PubMed ID: 4619937 [No Abstract] [Full Text] [Related]
24. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs]. Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256 [No Abstract] [Full Text] [Related]
25. [Rifampicin in the treatment of chronic pulmonary tuberculosis]. Pacheco CR; Cordero O; Sierra D; Pacheco J; Vázquez E Gac Med Mex; 1976 Jun; 107(6):505-11. PubMed ID: 976671 [No Abstract] [Full Text] [Related]
26. [Treatment of newly diagnosed patients with infiltrative and disseminated pulmonary tuberculosis]. Ursov IG; Krasnov VA; B1tashova VA; Kudelia OA; Volkova ZhA; Gromyko NI; Borovinskaia TA Probl Tuberk; 1998; (4):21-2. PubMed ID: 9771031 [TBL] [Abstract][Full Text] [Related]
27. [New and future drugs in pulmonary tuberculosis]. Grosset JH; Truffot-Pernot C; Lecoeur H Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():206-10. PubMed ID: 3174565 [No Abstract] [Full Text] [Related]
28. [Treatment of pleural and pulmonary tuberculosis by drug combinations including rifampicin. Early results]. Cornudella R; Garcia-Besada JA; Castellano A Rev Clin Esp; 1972 Jul; 126(1):59-64. PubMed ID: 5080189 [No Abstract] [Full Text] [Related]
29. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis]. Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883 [TBL] [Abstract][Full Text] [Related]
30. [Preliminary results of initial short-term chemotherapy with INH, RMP and EMB in intermittent and biphasic administration (the 3 plus 6 experiment)]. Anastasatu C; Bercea O; Barcan F; Stinghe R; Dinulică E; Marcovici M; Cristea M; Cărpinişan L; Gheorghiu M; Iancovici O; Ghinescu S Ftiziologia; 1974 May; 23(3):253-64. PubMed ID: 4842931 [No Abstract] [Full Text] [Related]
31. [Dynamics of the release of bacilli and the closing of caverns in newly identified tuberculosis patients undergoing different chemotherapeutic regimens]. Muratov VV; Pashkov IuN; Pospelov VV Probl Tuberk; 1981 Dec; (12):30-4. PubMed ID: 6801646 [No Abstract] [Full Text] [Related]
32. Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis. Pandey R; Sharma S; Khuller GK Int J Antimicrob Agents; 2004 Apr; 23(4):414-5. PubMed ID: 15081096 [No Abstract] [Full Text] [Related]
34. [Drug-resistant pulmonary tuberculosis at the penitentiaries]. Kononets AS Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326 [TBL] [Abstract][Full Text] [Related]
35. [A study on short-course chemotherapy for pulmonary tuberculosis. Initial intensive regimens containing streptomycin]. Suzuyama Y; Shigeno Y; Shigeno H; Nakazato H; Nagasawa M; Koga H; Tomita H; Tomonaga A; Yamaguchi K; Izumikawa K Kekkaku; 1984 Apr; 59(4):277-87. PubMed ID: 6748457 [No Abstract] [Full Text] [Related]
36. [Comparative characteristics of the use of rifadin and ethambutol in the complex treatment of patients with fibro-cavernous pulmonary tuberculosis]. Tarasova EF; Sagalovich VIa Probl Tuberk; 1974; (12):26-30. PubMed ID: 4445131 [No Abstract] [Full Text] [Related]
37. [Toward a modern treatment of pulmonary tuberculosis. 2. Bacteriologic and pharmacologic bases and short-term treatment]. Zegaya M Tunis Med; 1984 Nov; 62(7):487-94. PubMed ID: 6442475 [No Abstract] [Full Text] [Related]
38. [The therapeutic action of Rifampicin, a derivative of 3-(4-methyl-1-piperazinyl-iminomethyl)-rifamycin SV, in pulmonary tuberculosis]. Lucchesi M; Pallotta G; Rossi P; Sbampato M Ann Ist Carlo Forlanini; 1967; 27(3):199-227. PubMed ID: 5602885 [No Abstract] [Full Text] [Related]
39. [Use of pyrogenal in the combined treatment of torpid destructive forms of pulmonary tuberculosis]. Bilyk MA; Dudchik GKh Vrach Delo; 1982 Jan; (1):29-31. PubMed ID: 7073854 [No Abstract] [Full Text] [Related]
40. [Preliminary clinical observations on the use of Rifampicin in chronic cavitary pulmonary tuberculosis previously treated with and resistant to other drugs]. Mauro G Arch Tisiol Mal Appar Respir; 1968 Jun; 23(6):461-6. PubMed ID: 5309059 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]